Who founded Oncosenx?

Oncosenx was founded by Matthew Scholz, Matt Scholz in 2017.

Who are Oncosenx's investors?

Oncosenx's investors include Helios Capital.

How much funding has Oncosenx raised?

Oncosenx has disclosed $4.8M raised across 2 rounds.

Where is Oncosenx headquartered?

Oncosenx is headquartered in Seattle, US.

Oncosenx

Seattle, US · Founded 2017 · Delaware corporation · 1 known investors

OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.

Biotech Deep Tech Healthtech

Founders & leadership

Oncosenx was founded in 2017 by Matthew Scholz and Matt Scholz.

Matthew ScholzCo-founder

Matt Scholz

John LewisNamed on SEC filing

Gary HudsonNamed on SEC filing

Investors · 1

Helios CapitalMiami · $25K – $1Mvia Ryan Kriser · inferred

Reported raises · per SEC filings

Form D private placements

$4.8M disclosed across 2 rounds · 2017–2021

▶$650KraisedAug 2021 · 8 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Eric GarciaExecutive Officer
Stephen HilbertExecutive Officer
Gary HudsonExecutive Officer, Director, Promoter
John LewisExecutive Officer, Director, Promoter
Matthew ScholzExecutive Officer, Director, Promoter

Offering amount: $5M
Amount sold: $650K
First sale: Jul 2021
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4.1MraisedApr 2020 · 62 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Matthew ScholzExecutive Officer, Director
John LewisExecutive Officer, Director
Gary HudsonDirector

Offering amount: $5.5M
Amount sold: $4.1M
First sale: Dec 2017
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Oncosenx went on to found or lead other companies.

Matthew ScholzChief Executive OfficerFounded Oisin Biotechnologies +2 Kingsley AdvaniInvestorFounded Allocations

Competitors · 2

by search overlap

Exelixis31 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.

Bioworld24 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Oncosenx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Oncosenx do?: OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.
Who founded Oncosenx?: Oncosenx was founded by Matthew Scholz, Matt Scholz in 2017.
Who are Oncosenx's investors?: Oncosenx's investors include Helios Capital.
How much funding has Oncosenx raised?: Oncosenx has disclosed $4.8M raised across 2 rounds.
Where is Oncosenx headquartered?: Oncosenx is headquartered in Seattle, US.